EntrepreneurialCheck
Benedetta di Robilant estimated net worth profile

Benedetta di Robilant Net Worth (Estimated)

Founder at Dorian Therapeutics · YC S18

est. wealth $7.5M

Quick answer

Benedetta di Robilant's estimated net worth / paper wealth is $7.5M (range $5.2M–$11.2M) as of 2026.

Benedetta di Robilant is Founder at Dorian Therapeutics (YC S18). Independent Entrepreneurial Check model estimate from public YC data.

At a glance

NameBenedetta di Robilant
RoleFounder
CompanyDorian Therapeutics
YC batchS18
Est. company val$100.0M
Assumed ownership8%
Est. paper wealth / net worth$7.5M
$5.2M – $11.2M
  • Company status: Acquired
  • Education: Ph.D. in Biology from Stanford University
  • Region: United States of America
  • Industries: Healthcare, Therapeutics
  • Team size: 8
  • Website: http://www.doriantherapeutics.com

Who is Benedetta di Robilant?

Benedetta di Robilant is a co-founder of Dorian Therapeutics, a company focused on advancing the field of cell therapy.

Highlights:

  • Stanford University
  • Y Combinator S18
  • Research in therapeutic solutions

About Dorian Therapeutics

New therapeutics to rejuvenate tissue and treat age-related diseases

Model inputs

FAQ: Benedetta di Robilant net worth and Dorian Therapeutics valuation

What is Benedetta di Robilant's net worth?

Benedetta di Robilant's estimated net worth / paper wealth is $7.5M (range $5.2M–$11.2M) as of 2026. Entrepreneurial Check publishes an independent model-based estimate from public company and role data.

Benedetta di Robilant net worth

Benedetta di Robilant's estimated net worth / paper wealth is $7.5M (range $5.2M–$11.2M) as of 2026. This Benedetta di Robilant net worth figure is estimated paper wealth, not a verified statement of assets.

How much is Benedetta di Robilant worth?

Benedetta di Robilant's estimated net worth / paper wealth is $7.5M (range $5.2M–$11.2M) as of 2026. How much Benedetta di Robilant is worth here means estimated paper wealth from public company and role data — not financial advice.

How rich is Benedetta di Robilant?

Benedetta di Robilant's estimated net worth / paper wealth is $7.5M (range $5.2M–$11.2M) as of 2026. “How rich is Benedetta di Robilant” here means estimated paper wealth from public company and role data — not verified net worth or financial advice.

Benedetta di Robilant fortune

Benedetta di Robilant's estimated net worth / paper wealth is $7.5M (range $5.2M–$11.2M) as of 2026. This Benedetta di Robilant fortune figure is estimated paper wealth only, not a verified statement of assets.

Benedetta di Robilant equity value

Benedetta di Robilant's estimated net worth / paper wealth is $7.5M (range $5.2M–$11.2M) as of 2026. Benedetta di Robilant equity value on this page is modeled paper wealth from estimated ownership — not a disclosed cap table or verified net worth.

What is Dorian Therapeutics valuation?

Dorian Therapeutics's estimated valuation on Entrepreneurial Check is $100.0M. Independent model output, not a verified appraisal or official mark.

What is Dorian Therapeutics post-money valuation?

Dorian Therapeutics's estimated valuation on Entrepreneurial Check is $100.0M. That figure is a modeled post-money mark when a public raise is available — not a verified appraisal or official mark.

What is Dorian Therapeutics funding?

Dorian Therapeutics funding, when a public raise is available, is a model input on this Entrepreneurial Check profile. How much Dorian Therapeutics raised is not a complete cap table — figures are estimates only.

How much did Dorian Therapeutics raise?

How much Dorian Therapeutics raised, when disclosed, informs the estimated Dorian Therapeutics valuation and founder paper-wealth figures on this page. Independent estimate only — not a complete cap table or financial advice.

How much money did Dorian Therapeutics raise?

How much money Dorian Therapeutics raised, when a public figure is available, is a model input for the estimated Dorian Therapeutics valuation on this profile. Estimates only — not a complete cap table.

What is Dorian Therapeutics series funding?

Dorian Therapeutics series funding, when a public raise is disclosed, informs the estimated Dorian Therapeutics valuation here. Not a complete financing history.

What company is Benedetta di Robilant building?

Benedetta di Robilant is Founder at Dorian Therapeutics, a Y Combinator-backed startup (batch S18).

What does Dorian Therapeutics do?

Dorian Therapeutics — New therapeutics to rejuvenate tissue and treat age-related diseases

What YC batch is Benedetta di Robilant from?

Benedetta di Robilant is associated with Y Combinator batch S18.

Where did Benedetta di Robilant go to school?

Public profiles associate Benedetta di Robilant with Ph.D. in Biology from Stanford University.

Where is Benedetta di Robilant based?

Public directory data lists Benedetta di Robilant's region as United States of America.

What industry is Benedetta di Robilant in?

Benedetta di Robilant is listed under Healthcare, Therapeutics.

How big is Dorian Therapeutics?

Public data lists Dorian Therapeutics's team size as 8.

What is Dorian Therapeutics's status?

Dorian Therapeutics is listed as Acquired in public company data.

What else is notable about Benedetta di Robilant?

Stanford University.

Is Entrepreneurial Check affiliated with Y Combinator?

No. Entrepreneurial Check is an independent informational site and is not affiliated with, endorsed by, or sponsored by Y Combinator or the profiled companies.